3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy
Related Experiment Video
Updated: Feb 28, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Liang Yin1,2, Hai-Yan Xu3, Sui-Sheng Zheng3
1Department of Radiology, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, Jiangxi, China.
Insights
Cardiac magnetic resonance imaging reveals coronary microvascular dysfunction in hypertrophic cardiomyopathy patients, even in non-hypertrophic segments. Abnormal perfusion is linked to fibrosis and hypertrophy severity.
Area of Science:
- Cardiology
- Medical Imaging
- Biophysics
Background:
- Hypertrophic cardiomyopathy (HCM) is associated with coronary microvascular dysfunction (CMD).
- Assessing CMD in HCM patients is crucial for diagnosis and management.
- Cardiac magnetic resonance (CMR) offers advanced imaging capabilities for myocardial assessment.
Purpose of the Study:
- To evaluate differences in CMD in HCM patients using CMR first-pass perfusion and late gadolinium enhancement (LGE).
- To correlate perfusion parameters with hypertrophy and fibrosis severity in HCM.
- To determine the utility of 3.0 T CMR perfusion imaging in detecting early CMD in HCM.
Main Methods:
- Forty-seven HCM patients and 21 healthy controls underwent 3.0 T CMR at rest.
- Imaging included cine, first-pass myocardial perfusion, and LGE.
- Myocardial segments were analyzed for end-diastolic wall thickness (EDTH), LGE, time to peak (Tpeak), maximal up-slope (Slopemax), and peak signal intensity (SIpeak).
- Statistical analyses included ANOVA, Kruskal-Wallis, and Spearman correlation tests.
Main Results:
- HCM segments showed increased Tpeak and decreased Slopemax and SIpeak compared to controls, even in non-LGE/non-hypertrophic areas.
- Tpeak was significantly higher in LGE/hypertrophic segments and increased with LGE severity.
- EDTH and LGE were positively correlated with Tpeak.
- Abnormal perfusion was identified in non-LGE and non-hypertrophic segments of HCM patients.
Conclusions:
- 3.0 T CMR myocardial perfusion imaging can detect abnormal perfusion in HCM patients, suggesting early CMD.
- Abnormal perfusion is associated with the severity of myocardial fibrosis (LGE) and hypertrophy.
- CMR perfusion imaging may aid in the early diagnosis of CMD in HCM.
Abstract:
This study aimed to assess coronary microvascular dysfunction (CMD) differences in hypertrophic cardiomyopathy (HCM) patients using cardiac magnetic resonance (CMR) first-pass perfusion and late gadolinium enhancement imaging. Forty-seven patients with HCM and twenty-one healthy volunteers underwent CMR at rest. Imaging protocols included short axis cine, first-pass myocardial perfusion, and late gadolinium enhancement (LGE). Left ventricular end-diastolic wall thickness (EDTH), LGE, time to peak (Tpeak), maximal up-slope (Slopemax), and peak signal intensity (SIpeak) were assessed for each myocardial segment. The HCM myocardial segments were grouped by the degree of LGE and hypertrophy. Tpeak, SIpeak, Slopemax and EDTH in multiple groups were assessed and compared by ANOVA test/Kruskal-Wallis test. The Spearman correlation test was used to determine the relationships between EDTH, LGE and perfusion parameters (Tpeak, Slopemax and SIpeak). Compared to control group segments, Tpeak increased while Slopemax and SIpeak decreased in non-LGE/non-hypertrophic segments and LGE/hypertrophic segments in the HCM group, while Tpeak increased more significantly in LGE/hypertrophic segments (all p < 0.05). Tpeak statistically increased with increasing degrees of myocardial LGE (p < 0.01). Differences in Tpeak, SIpeak and EDTH were observed between segments with and without hypertrophy (p < 0.05). EDTH and LGE were positively correlated with Tpeak (r = 0.279, p = 0.031 and r = 0.237, p < 0.001). 3.0 T magnetic resonance myocardial perfusion imaging identifies abnormal perfusion in non-LGE and non-hypertrophic segments of HCM patients, and it may be helpful in the early diagnosis of coronary microvascular dysfunction in HCM. This abnormal perfusion is associated with the severity of myocardial fibrosis and the degree of hypertrophy.
More Related Videos
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
10:16Retrograde Perfusion and Filling of Mouse Coronary Vasculature as Preparation for Micro Computed Tomography Imaging
Published on: February 10, 2012
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI